Bret Jensen

Specializing in biotech stocks, small caps, managing optimized portfolios
Bret Jensen
Specializing in biotech stocks, Small Caps, managing optimized portfolios
Contributor since: 2010
Company: Bretjenseninvests.com
Gilead: Buyout Targets Abound
Momentum Stocks Get DeFANGed!
Some Signs Of Life In Biotech
Gilead Has Decided To Buy Itself
Investing Lessons From Hillarycare
Relypsa: Buyout Appears Imminent
When Will The Beatings Cease?
The ABC's Of Big Biotech Investing
Is Global Recession On The Horizon?
AbbVie: The Safe/Cheap 4% Yield Play
How Low Can Oil And The Markets Go?
Biotech Bargains Abound
The Check Finally Comes Due